ArticleFrontiers in pharmacology2022

Overexpression of ABCB1 Associated With the Resistance to the KRAS-G12C Specific Inhibitor ARS-1620 in Cancer Cells.

Xing-Duo Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.